Data Bridge Market Research analyses that the Cushing's disease Market was valued at USD 333.80 million in 2021 and is expected to reach USD 686.89 million by 2029, registering a CAGR of 9.44% during the forecast period of 2022 to 2029.

In recent years, the Cushing's disease market is anticipated to grow rapidly during the forecast period. Cushing's syndrome is a group of symptoms brought on by a high hormone cortisol level. The syndrome, also known as hypercortisolism, is frequently induced by corticosteroid medication adverse effects. Inflammation and autoimmune diseases are commonly treated with corticosteroids. Iatrogenic Cushing's syndrome and endogenous Cushing's syndrome are the two kinds of Cushing's syndrome. Weight gain, adipose tissue deposits around the abdomen and back, purple stretch marks, thinner skin that is easily bruised, acne, and other symptoms are common.

High blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat mass between the shoulders, and delicate skin that heals slowly are all symptoms and indicators of Cushing's syndrome. Cushing's syndrome is caused by two main factors: excessive cortisol-like medicines like prednisone, and tumours formed by adrenal glands overproducing cortisol. Other tumors, such as those linked to hereditary illnesses including multiple endocrine neoplasia type 1 and Carney complex, may potentially be responsible for this condition. In most situations, a combination of surgery, radiation, and chemotherapy can be used to treat and cure the condition.

Global Cushing's disease Market Scope

The Cushing's disease market is segmented on the basis of treatment type, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Type

  • Surgery
  • Radiation Therapy
  • Drugs
  • Ketoconazole
  • Mitotane
  • Aminoglutethimide
  • Metyrapone
  • Mifepristone
  • Etomidate
  • Pasireotide
  • Others


  • Petrosal Sinus Sampling
  • Saliva Test
  • Urine and Blood Tests
  • Imaging Tests
  • Computerized tomography (CT) scans
  • Magnetic resonance imaging (MRI)
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others


  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Grab a sample copy of the report here:

Cushing's disease Market Regional Analysis/Insights

The Cushing's disease market is analysed and market size insights and trends are provided by country, treatment type, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Cushing's disease market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the Cushing's disease market because of the rising number of research activities and the growing prevalence of obesity population in this region. Additionally, rising healthcare expenditure and favorable government policies will further propel the market's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to the increasing level of disposable income in this region. Also, the development of healthcare infrastructure and rising awareness about the diseases will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Cushing's disease Market Share Analysis

The Cushing's disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Cushing's disease market.

Some of the major players operating in the Cushing's disease market are:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Zydus Cadila (India)
  • AstraZeneca (UK)
  • Johnson & Johnson (US)
  • Bayer AG (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Bristol-Myers Squibb Company (US)
  • Eli Lilly and Company (US)
  • Strides Pharma Science Limited (India)
  • Cipla Inc. (US)
  • LEO Pharma A/S (Denmark)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Hikma Pharmaceuticals PLC (UK)

Get Full Access of reports @


  • Chapter One: Introduction
  • Chapter Two: Market Segmentation
  • Chapter Three: Market Overview
  • Chapter Four: Executive Summary
  • Chapter Five: Premium Insights
  • Chapter Six: Global Cushing’s Disease Market by Product & Procedure type

Get TOC Details:

Browse Related Reports @

About Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Data Bridge Market Research
Tel: +1-888-387-2818  
Email: [email protected]